Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pang

Showing results (801-810 of 824) with videos related to

Pageof 83
Sort By:
Elife|February 5, 2020
Discovery of several thousand highly diverse circular DNA virusesMichael J Tisza, Diana V Pastrana, Nicole L Welch, et al.
European Journal of Heart Failure|October 31, 2023
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failureJozine M Ter Maaten, Alexandre Mebazaa, Beth Davison, et al.
The New England Journal of Medicine|July 22, 2015
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1Susanna Naggie, Curtis Cooper, Michael Saag, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 13, 2020
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14Bruce K Patterson, Harish Seethamraju, Kush Dhody, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
Circulation. Cardiovascular Quality and Outcomes|September 24, 2021
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency DepartmentWilliam B Stubblefield, Cathy A Jenkins, Dandan Liu, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
Pageof 83

Showing results (801-810 of 824) with videos related to

Sort By:
Pageof 83
Elife|February 5, 2020
Discovery of several thousand highly diverse circular DNA virusesMichael J Tisza, Diana V Pastrana, Nicole L Welch, et al.
European Journal of Heart Failure|October 31, 2023
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failureJozine M Ter Maaten, Alexandre Mebazaa, Beth Davison, et al.
The New England Journal of Medicine|July 22, 2015
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1Susanna Naggie, Curtis Cooper, Michael Saag, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 13, 2020
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14Bruce K Patterson, Harish Seethamraju, Kush Dhody, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
Circulation. Cardiovascular Quality and Outcomes|September 24, 2021
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency DepartmentWilliam B Stubblefield, Cathy A Jenkins, Dandan Liu, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
Pageof 83